Bin Zhu

7.3k total citations · 1 hit paper
82 papers, 2.7k citations indexed

About

Bin Zhu is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Bin Zhu has authored 82 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 70 papers in Molecular Biology, 22 papers in Cancer Research and 8 papers in Oncology. Recurrent topics in Bin Zhu's work include RNA modifications and cancer (15 papers), Cancer-related molecular mechanisms research (14 papers) and Cancer-related gene regulation (13 papers). Bin Zhu is often cited by papers focused on RNA modifications and cancer (15 papers), Cancer-related molecular mechanisms research (14 papers) and Cancer-related gene regulation (13 papers). Bin Zhu collaborates with scholars based in China, Saudi Arabia and United States. Bin Zhu's co-authors include Caiping Ren, Weidong Liu, Guangyi Li, Changqing Zhang, Xingjun Jiang, Qingcheng Yang, Dongdong Cheng, Yan Jin, Kexin Liu and Junjie Gao and has published in prestigious journals such as The Journal of Experimental Medicine, SHILAP Revista de lepidopterología and Biomaterials.

In The Last Decade

Bin Zhu

75 papers receiving 2.7k citations

Hit Papers

Contribution of ferroptosis and GPX4’s dual functions to ... 2022 2026 2023 2024 2022 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Contribution of ferroptosis and GPX4’s dual functions to osteoarthritis progression
    2022 317 citations Bin Zhu et al. profile →

Peers

Bin Zhu
Yiping Wu China
Fengjing Guo China
Jianda Zhou China
Shourong Wu China
Xiaofeng Wang China
Anjing Chen China
Radhakrishnan Vishnubalaji Qatar
Feng Lu China
Yiping Wu China
Bin Zhu
Citations per year, relative to Bin Zhu Bin Zhu (= 1×) peers Yiping Wu

Countries citing papers authored by Bin Zhu

Since Specialization
Citations

This map shows the geographic impact of Bin Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bin Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bin Zhu more than expected).

Fields of papers citing papers by Bin Zhu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bin Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bin Zhu. The network helps show where Bin Zhu may publish in the future.

Co-authorship network of co-authors of Bin Zhu

This figure shows the co-authorship network connecting the top 25 collaborators of Bin Zhu. A scholar is included among the top collaborators of Bin Zhu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bin Zhu. Bin Zhu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Shasha, Hui Liu, Weidong Liu, et al.. (2023). ESRG is critical to maintain the cell survival and self-renewal/pluripotency of hPSCs by collaborating with MCM2 to suppress p53 pathway. International Journal of Biological Sciences. 19(3). 916–935. 11 indexed citations
2.
Xu, Hongjuan, Yihan Li, Ning Shi, et al.. (2023). FLOT2 promotes nasopharyngeal carcinoma progression through suppression of TGF-β pathway via facilitating CD109 expression. iScience. 27(1). 108580–108580. 4 indexed citations
3.
Du, Chuanchao, Mengxue Zhou, Fei Jia, et al.. (2021). D-arginine-loaded metal-organic frameworks nanoparticles sensitize osteosarcoma to radiotherapy. Biomaterials. 269. 120642–120642. 105 indexed citations
4.
Hai, Bao, Xiaoyu Pan, Chuanchao Du, et al.. (2020). <p>LncRNA XIST Promotes Growth of Human Chordoma Cells by Regulating miR-124-3p/iASPP Pathway</p>. OncoTargets and Therapy. Volume 13. 4755–4765. 17 indexed citations
5.
Zhou, Zhifei, Fen Liu, Lulu Wang, et al.. (2020). Inflammation has synergistic effect with nicotine in periodontitis by up‐regulating the expression of α7 nAChR via phosphorylated GSK‐3β. Journal of Cellular and Molecular Medicine. 24(4). 2663–2676. 17 indexed citations
6.
Liu, Hui, Shasha Li, Caiping Ren, et al.. (2020). Generation of an ESRG Pr-tdTomato reporter human embryonic stem cell line, CSUe011-A, using CRISPR/Cas9 editing. Stem Cell Research. 48. 101983–101983. 4 indexed citations
7.
Zhu, Bin, et al.. (2019). miR-942 promotes proliferation and metastasis of hepatocellular carcinoma cells by inhibiting RRM2B. SHILAP Revista de lepidopterología.
8.
An, Yu, Peng Xue, Liqiang Zhang, et al.. (2018). Autophagy promotes MSC-mediated vascularization in cutaneous wound healing via regulation of VEGF secretion. Cell Death and Disease. 9(2). 58–58. 155 indexed citations
9.
Lei, Yong, Yunlong Ma, Bin Zhu, et al.. (2018). Oleandrin synergizes with cisplatin in human osteosarcoma cells by enhancing cell apoptosis through activation of the p38 MAPK signaling pathway. Cancer Chemotherapy and Pharmacology. 82(6). 1009–1020. 12 indexed citations
10.
Cheng, Dongdong, et al.. (2018). EEF1D overexpression promotes osteosarcoma cell proliferation by facilitating Akt-mTOR and Akt-bad signaling. Journal of Experimental & Clinical Cancer Research. 37(1). 50–50. 26 indexed citations
11.
Wang, Lei, et al.. (2018). Roles of flotillins in tumors. Journal of Zhejiang University SCIENCE B. 19(3). 171–182. 24 indexed citations
12.
Feldman, et al.. (2017). Cost Per Additional Responder Associated With Ixekizumab and Etanercept in the Treatment of Moderate-to-Severe Psoriasis.. PubMed. 16(12). 1246–1252. 3 indexed citations
13.
Zhang, Zhenyu, Bin Zhu, Yunbo Zhan, et al.. (2017). Regulation of UHRF1 by microRNA-378 modulates medulloblastoma cell proliferation and apoptosis. Oncology Reports. 38(5). 3078–3084. 19 indexed citations
14.
Cheng, Dongdong, et al.. (2017). Down-regulation of RPS9 Inhibits Osteosarcoma Cell Growth through Inactivation of MAPK Signaling Pathway. Journal of Cancer. 8(14). 2720–2728. 24 indexed citations
15.
Liu, Jie, Wei Huang, Caiping Ren, et al.. (2015). Flotillin-2 promotes metastasis of nasopharyngeal carcinoma by activating NF-κB and PI3K/Akt3 signaling pathways. Scientific Reports. 5(1). 11614–11614. 47 indexed citations
16.
Zhu, Liang, et al.. (2014). RelB regulates Bcl-xl expression and the irradiation-induced apoptosis of murine prostate cancer cells. Biomedical Reports. 2(3). 354–358. 19 indexed citations
17.
Zhou, Wen, Xiangling Feng, Caiping Ren, et al.. (2013). Over-expression of BCAT1, a c-Myc target gene, induces cell proliferation, migration and invasion in nasopharyngeal carcinoma. Molecular Cancer. 12(1). 53–53. 121 indexed citations
18.
Zhu, Bin, et al.. (2012). Study on drug resistance of Pseudomonas aeruginosa plasmid-mediated AmpC β-lactamase. Molecular Medicine Reports. 7(2). 664–668. 10 indexed citations
19.
Zhang, Hongbo, Weidong Liu, Xiangling Feng, et al.. (2011). Identification of ABCG2+ cells in nasopharyngeal carcinoma cells. Oncology Reports. 27(4). 1177–1187. 11 indexed citations
20.
Lv, Jin, Xiufeng Cao, LV Ji, et al.. (2010). Association of Wnt1/β-Catenin with Clinical Pathological Characteristics and Prognosis of Esophageal Squamous Cell Carcinoma. Genetic Testing and Molecular Biomarkers. 14(3). 363–369. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yiping Wu Breakdown of academic impact, for papers by Fengjing Guo Breakdown of academic impact, for papers by Jianda Zhou Breakdown of academic impact, for papers by Shourong Wu Breakdown of academic impact, for papers by Xiaofeng Wang Breakdown of academic impact, for papers by Anjing Chen Breakdown of academic impact, for papers by Radhakrishnan Vishnubalaji Breakdown of academic impact, for papers by Feng Lu
Rankless by CCL
2026